Health News-RSS Feeds

Subscribe to Health News-RSS Feeds feed Health News-RSS Feeds
Reuters.com is your source for breaking news, business, financial and investing news, including personal finance and stocks. Reuters is the leading global provider of news, financial information and technology solutions to the world's media, financial institutions, businesses and individuals.
Updated: 7 min 23 sec ago

Turkish healthcare group MLP begins marketing IPO to investors

January 8, 2018 - 9:07pm
LONDON (Reuters) - MLP Saglik Hizmetleri, Turkey's largest private healthcare service provider, on Monday started marketing its initial public offering to investors, in which it aims to raise primary proceeds of around 500 million lira ($133 million), the bookrunner on the sale said.

Ablynx shares soar after rejects Novo Nordisk's $3.1 billion bid

January 8, 2018 - 8:59pm
COPENHAGEN/BRUSSELS (Reuters) - Denmark's Novo Nordisk, the world's biggest insulin maker, went public with a 2.6 billion euro ($3.1 billion) bid for Belgian biotech group Ablynx on Monday as it seeks a new source of growth by bolstering its treatments for rare blood disorders.

Shire to separate ADHD drugs before possible spin-off, cuts 2020 target

January 8, 2018 - 8:46pm
LONDON (Reuters) - London-listed pharmaceutical group Shire said on Monday it would create two distinct business units for its rare disease and hyperactivity medicines before deciding later this year whether to spin off the latter into a separately listed group.

Hot flashes caused by cancer therapy can be prevented, treated

January 8, 2018 - 8:39pm
(Reuters Health) - Cancer patients with hot flashes related to hormone therapy should know that these uncomfortable symptoms can be managed, according to a recently published resource for patients.

$11 billion biotech binge fuels forecasts of 2018 M&A surge

January 8, 2018 - 8:35pm
LONDON (Reuters) - An $11 billion burst of biotech bids in just four days has fueled expectations of a 2018 surge in life science deals as large drugmakers shop for promising assets from smaller rivals.

India top court sets aside order cancelling bigger tobacco health warnings

January 8, 2018 - 8:27pm
NEW DELHI (Reuters) - India's Supreme Court on Monday put on hold a lower court's order that quashed federal rules mandating larger health warnings on tobacco packages, in a setback for the $11 billion tobacco industry but a relief for the government.

Shire to separate ADHD drugs ahead of possible spin-off, cuts outlook

January 8, 2018 - 8:19pm
LONDON (Reuters) - London-listed pharmaceutical group Shire said on Monday it would create two distinct business units for its rare disease and hyperactivity medicines ahead of deciding later this year whether to spin off the latter into a separately listed group.

Allianz to invest $59 million in digital U.S. healthcare provider

January 8, 2018 - 7:31pm
FRANKFURT (Reuters) - The German insurer Allianz said on Monday that it has agreed to invest $59 million in American Well, a digital healthcare provider.

Sanofi and Regeneron boost investment in cancer drug cemiplimab

January 8, 2018 - 7:28pm
PARIS (Reuters) - France's Sanofi and U.S Regeneron said on Monday they would inject an additional $1 billion in the development of cemiplimab, an antibody that could, if successful, be used to treat a wide range of cancers.

German drugmaker Dermapharm plans March IPO - sources

January 8, 2018 - 7:21pm
FRANKFURT (Reuters) - German non-prescription drugmaker Dermapharm is planning to list on the Frankfurt stock exchange before the Easter holidays, in a deal that is expected to value the company at more than 1 billion euros ($1.2 billion), people familiar with the matter said.‎

Axovant shares plunge after key drug program scrapped

January 8, 2018 - 6:21pm
(Reuters) - Axovant Sciences Ltd's shares fell nearly 50 percent on Monday after the company scrapped its intepirdine program following the failure of its lead experimental treatment in a mid-stage study on patients suffering from a type of dementia.

Novo Nordisk's $3.1 billion Ablynx bid rejected by Belgian biotech

January 8, 2018 - 6:14pm
COPENHAGEN/BRUSSELS (Reuters) - Denmark's Novo Nordisk, the world's biggest maker of insulin, went public with a 2.6 billion euro ($3.1 billion) bid for Belgian biotech group Ablynx on Monday as it seeks to bolster its treatments for rare blood disorders.

Death toll in South Africa listeria outbreak jumps to 61

January 8, 2018 - 5:53pm
JOHANNESBURG (Reuters) - The death toll from an outbreak of listeria in South Africa has jumped beyond 60 in the past month, health authorities said on Monday, adding they had closed a poultry abattoir where the bug that causes the disease had been detected.

Regeneron forms consortium to accelerate gene sequencing project

January 8, 2018 - 5:33pm
(Reuters) - Regeneron Pharmaceuticals Inc on Monday announced a collaboration with rival drugmakers that will speed its effort to collect genetic information on 500,000 people in the UK Biobank database, a project it believes could help accelerate new drug discovery and improve approval success rates.

Perrigo hires Gerresheimer ex-boss Rohrhoff as new CEO

January 8, 2018 - 12:33pm
(Reuters) - Generic drugmaker Perrigo Company Plc appointed Uwe Rohrhoff, former CEO of Gerresheimer AG, as its new chief executive, the company said on Monday.

Sanofi to market new hemophilia drug in deal with Alnylam

January 8, 2018 - 12:32pm
PARIS (Reuters) - French pharmaceutical group Sanofi said it has obtained the right to develop and sell a new hemophilia drug in a restructuring of its partnership with U.S. Alnylam Pharmaceuticals.

Pfizer ends research for new Alzheimer's, Parkinson's drugs

January 8, 2018 - 1:39am
NEW YORK (Reuters) - Pfizer Inc is abandoning research to find new drugs aimed at treating Alzheimer's and Parkinson's disease, the U.S. pharmaceutical company announced on Saturday.

Zambia declares curfew in Lusaka slum struck by cholera

January 7, 2018 - 9:08pm
LUSAKA (Reuters) - Zambia has declared a curfew in a poor Lusaka township badly affected by a cholera outbreak that has killed 58 people across the country since September, the government said on Sunday.

Court voids Baltimore law requiring 'no abortion' clinic disclaimers

January 6, 2018 - 3:19am
(Reuters) - A federal appeals court on Friday declared unconstitutional a Baltimore law requiring pregnancy clinics that do not offer or refer women for abortions to post signs disclosing that fact in their waiting rooms.

ADHD drug tied to heart defects in babies

January 6, 2018 - 2:40am
(Reuters Health) - - Pregnant women who take drugs like Ritalin and Concerta for attention deficit hyperactivity disorder (ADHD) are more likely than those who don’t to have babies with heart deformities and other birth defects, a recent study suggests.

Pages